Quantcast
Channel: Forbes - William Ackman
Viewing all articles
Browse latest Browse all 122

Valeant Admits To 'Improper' Conduct, Ousts CEO, And Could Break Up

$
0
0
Valeant Pharmaceuticals just issued a statement saying that it would begin a search to replace longtime chief executive Michael Pearson, and that William Ackman, the chief executive of hedge fund Pershing Square Management and a major shareholder, would be taking a seat on the board.

Viewing all articles
Browse latest Browse all 122

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>